Oncologic Surgery, Centre Oscar Lambret, Lille, France.
Oncologic Surgery, CHU de Liège, Liège, Belgium.
Ann Surg Oncol. 2020 Oct;27(10):3891-3897. doi: 10.1245/s10434-020-08471-0. Epub 2020 May 29.
The outcomes of paraaortic lymphadenectomy were compared for the treatment of gynecological malignancies to identify the most appropriate surgical approach.
Our retrospective, multicentric study included 1304 patients who underwent paraaortic lymphadenectomy for gynecological malignancies. The patients were categorized into the following five groups based on treatment type: transperitoneal laparoscopy (group A, n = 198), extraperitoneal laparoscopy (group B, n = 681), robot-assisted transperitoneal laparoscopy (group C, n = 135), robot-assisted extraperitoneal laparoscopy (group D, n = 44), and laparotomy (group E, n = 246).
The prevalence of cancer types differed according to the surgical approach: there were more ovarian cancers in group E and more cervical cancers in groups B and D (p < 0.001). Estimated blood loss was higher in group E (844.2 mL) than in groups treated with minimally invasive interventions (115.8-141.5 mL, p < 0.005). For infrarenal dissection, fewer nodes were removed in group C compared with the other approaches (16 vs. 21 nodes, respectively, p < 0.05). The average operative time ranged from 169 min for group A to 247 min for group E (p < 0.001). Length of hospital stay was 14 days for group E versus 3.5 days for minimally invasive procedures (p < 0.05). The early postoperative grade 3 and superior Dindo-Clavien complications occurred in 9-10% of the patients in groups B-D, 15% of the patients in group E, and only 3% and 4% for groups A and C, respectively. The most common complication was lymphocele.
Laparotomy increases preoperative and postoperative morbidity. The robot-assisted transperitoneal approach demonstrated a poorer lymph node yield than laparotomy and extraperitoneal approaches.
比较了腹主动脉旁淋巴结清扫术治疗妇科恶性肿瘤的结果,以确定最适宜的手术方法。
我们的回顾性多中心研究纳入了 1304 例因妇科恶性肿瘤行腹主动脉旁淋巴结清扫术的患者。根据治疗方式将患者分为以下 5 组:经腹腔腹腔镜组(A 组,n=198)、经腹膜外腹腔镜组(B 组,n=681)、机器人辅助经腹腔腹腔镜组(C 组,n=135)、机器人辅助经腹膜外腹腔镜组(D 组,n=44)和剖腹手术组(E 组,n=246)。
不同手术方式的癌症类型发生率不同:E 组卵巢癌更多,B 组和 D 组宫颈癌更多(p<0.001)。E 组(844.2ml)估计出血量高于微创组(115.8-141.5ml,p<0.005)。对于肾下部分的解剖,C 组切除的淋巴结比其他方法少(分别为 16 个和 21 个淋巴结,p<0.05)。平均手术时间范围从 A 组的 169 分钟到 E 组的 247 分钟(p<0.001)。E 组的住院时间为 14 天,微创组为 3.5 天(p<0.05)。B-D 组中 9-10%的患者、E 组中 15%的患者出现术后 3 级及以上 Dindo-Clavien 并发症,而 A 组和 C 组仅分别有 3%和 4%的患者出现该并发症。最常见的并发症是淋巴囊肿。
剖腹手术增加了术前和术后的发病率。机器人辅助经腹腔入路的淋巴结清扫效果不如剖腹手术和经腹膜外入路。